Saturna Capital Corp Pfizer Inc Transaction History

Saturna Capital Corp

$7.24 Billion
Q4 2024

A detailed history of Saturna Capital Corp transactions in Pfizer Inc stock. As of the latest transaction made, Saturna Capital Corp holds 442,650 shares of PFE stock, worth $11.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

442,650

Previous 778,150 43.12%

Holding current value

$11.5 Million

Previous $22.5 Million 47.85%

% of portfolio

0.16%

Previous 0.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$24.8 - $30.19 $8.32 Million - $10.1 Million	-335,500 Reduced 43.12%	442,650 $11.7 Million
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $638,485 - $723,539	-23,050 Reduced 2.88%	778,150 $22.5 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $7.58 Million - $8.88 Million	-300,030 Reduced 27.24%	801,200 $22.4 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $776 - $891	30 Added 0.0%	1,101,230 $30.6 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $1.5 Million - $1.95 Million	-57,405 Reduced 4.95%	1,101,200 $31.7 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $129,739 - $151,652	-4,043 Reduced 0.35%	1,158,605 $38.4 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $384,497 - $444,854	10,645 Added 0.92%	1,162,648 $42.6 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $728,439 - $948,321	-18,493 Reduced 1.58%	1,152,003 $47 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $13,735 - $17,930	-329 Reduced 0.03%	1,170,496 $60 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $2.19 Million - $2.67 Million	-50,054 Reduced 4.1%	1,170,825 $51.2 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $29,313 - $34,757	630 Added 0.05%	1,220,879 $64 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $245,220 - $303,858	5,360 Added 0.44%	1,220,249 $63.2 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $28,510 - $42,262	690 Added 0.06%	1,214,889 $68.5 Million
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $27,318 - $35,092	696 Added 0.06%	1,214,199 $52.2 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $131,071 - $148,482	3,650 Added 0.3%	1,213,503 $47.5 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $377,499 - $425,743	11,272 Added 0.94%	1,209,853 $43.8 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $453,685 - $576,900	13,555 Added 1.14%	1,198,581 $44.1 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $571 - $670	-18 Reduced -0.0%	1,185,026 $43.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $5,120 - $6,211	-170 Reduced 0.01%	1,185,044 $38.8 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $170,289 - $243,305	-6,300 Reduced 0.53%	1,185,214 $43.4 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $34,895 - $39,601	1,060 Added 0.09%	1,191,514 $46.7 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $39,507 - $51,230	1,216 Added 0.1%	1,190,454 $42.8 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $503,297 - $565,087	-13,610 Reduced 1.13%	1,189,238 $51.5 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $278,137 - $305,580	7,417 Added 0.62%	1,202,848 $51.1 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $7,694 - $8,772	200 Added 0.02%	1,195,431 $52.2 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $3,447 - $4,181	-100 Reduced 0.01%	1,195,231 $52.7 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $19,784 - $22,952	-620 Reduced 0.05%	1,195,331 $42.4 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $186,056 - $197,412	5,594 Added 0.47%	1,195,951 $43.3 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $107,384 - $118,295	3,464 Added 0.29%	1,190,357 $42.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,186,893	1,186,893 $39.9 Million

Others Institutions Holding PFE

# of Institutions

3,249

Shares Held

3.65B

Call Options Held

78.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Pfizer Inc Transaction History